Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial

2023Contemporary Clinical TrialsJournal

10.1016/j.cct.2023.107108 Full text10 citations

Authors

45 authors across 45 institutions in 4 countries.

Jae-Sung LimFirst author
Juneyoung Lee
Yeonwook Kang
Hyun-Tae Park
Dong-Eog Kim
Jae-Kwan Cha
Tai Hwan Park
Jae-Hyuk Heo
Kyung Bok Lee
Jong-Moo Park
Mi Sun Oh
Eung-Gyu Kim
Dae-Il Chang

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Stroke Rehabilitation and Recoverylevel 3 · 0.12
Phosphodiesterase function and regulationlevel 3 · 0.11
Dementia and Cognitive Impairment Researchlevel 3 · 0.11

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 10, 2026
2023 · Contemporary Clinical Trials · 10 citations
https://openalex.org/W4318447367

New Generation University College (ET)

Sacred Heart Hospital (NG)

Jong-Ho Park

Keun‐Hwa Jung

as printed: Keun-Hwa Jung

Sang Min Sung

Jong-Won Chung

Yong-Seok Lee

New Generation University College (ET)

Hee-Joon BaeSenior authorCorresponding

Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial · Sankore